Every quarter, ARM publishes fresh data that highlights sector trends in clinical trials, investment, and developer growth. We supplement our data releases with periodic commentary, the Sector Snapshot, that contextualizes what’s new, what’s important, and why it matters.
You can access the data, broken down by category, and the editions of our Sector Snapshot below.
Access a full breakdown of global clinical trials within the cell and gene therapy sector.
A quick glimpse at the total number of therapeutic developers globally.
An overview of investment figures, equity performance, and financial deals that shape the sector.
ARM commentary that spotlights notable trends and stories driving the sector.
A review of sector data from 2022 and highlighting the trends shaping gene editing. Our CEO Tim Hunt lays out a recap of 2022 and what his vision for ARM is in 2023 and beyond.